DSM-Firmenich has agreed to pay US$33m to settle claims brought by direct purchasers alleging that the company participated in a scheme to fix prices in the fragrance industry between January 2018 and April 2023.
The proposed settlement would resolve the alleged claims against the fragrance and flavour maker and its subsidiaries.
This settlement comes as part of a wider antitrust case against major fragrance suppliers following investigations into suspected coordination within the industry.
The other principal defendants named in the case were Givaudan, IFF and Symrise.
IFF resolved certain claims, reaching a settlement with each of the three plaintiff groups for a combined value of $44m, while Symrise was cleared of allegations and is no longer a remaining defendant.
As part of the settlement deal, DSM-Firmenich has agreed to cooperate with plaintiffs as they pursue claims against other defendants, potentially giving plaintiffs additional evidence.
A spokesperson from DSM-Firmenich told Cosmetics Business: “DSM-Firmenich confirms that it has reached an agreement to settle one of the US class action lawsuits, brought in response to the antitrust investigation in the US.
“This settlement received preliminary approval from the US District Court of New Jersey on 4 August 2026.
“The settlement resolves the claims asserted against DSM-Firmenich brought by direct purcha
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.
